Research Article
Expression of the Matrix Metalloproteases 2, 14, 24, and 25 and Tissue Inhibitor 3 as Potential Molecular Markers in Advanced Human Gastric Cancer
Table 1
Clinicopathological characteristics of patients with a diagnosis of gastric cancer included in the study.
| | Characteristic | (%) |
| | Age (years) | | | Average ± standard deviation | 58 ± 12.4 | | Range | 29–78 | | Gender | | | Feminine | 9 (52.9) | | Masculine | 8 (47.1) | | Histological type | | | Adenocarcinoma | 17 (100) | | Histological differentiation | | | Well | 1 (5.9) | | Moderate | 2 (11.8) | | Poor | 11 (64.7) | | Nondifferentiated | 1 (5.9) | | Unknown | 2 (11.8) | | Macroscopic classification | | | Incipient | (0) | | Advanced | 17 (100) | | Size | | | Less than 20 mm | (0) | | 21–50 mm | 8 (47.1) | | Greater than 50 mm | 9 (52.9) | | Anatomic position (third) | | | Upper | 4 (23.5) | | Middle | 4 (23.5) | | Lower | 6 (35.3) | | Upper/middle | 1 (5.9) | | Middle/lower | 1 (5.9) | | Total | 1 (5.9) |
|
|
